Pieris Pharmaceuticals (PIRS) Short Interest Ratio & Short Volume $17.30 +0.05 (+0.29%) (As of 11/1/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Pieris Pharmaceuticals Short Interest DataPieris Pharmaceuticals (PIRS) has a short interest of 26,800 shares, representing 2.03% of the float (the number of shares available for trading by the public). This marks a -2.19% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 47,395 shares to cover all short positions.Current Short Interest26,800 sharesPrevious Short Interest27,400 sharesChange Vs. Previous Month-2.19%Dollar Volume Sold Short$432,016.00Short Interest Ratio0.2 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares1,320,000 sharesFloat Size1,320,000 sharesShort Percent of Float2.03%Today's Trading Volume4,608 sharesAverage Trading Volume47,395 sharesToday's Volume Vs. Average10% Short Selling Pieris Pharmaceuticals? Sign up to receive the latest short interest report for Pieris Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPIRS Short Interest Over TimePIRS Days to Cover Over TimePIRS Percentage of Float Shorted Over Time Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Pieris Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/202426,800 shares $432,016.00 -2.2%2.0%0.2 $16.12 9/30/202427,400 shares $458,676.00 -24.7%2.1%0.2 $16.74 9/15/202436,400 shares $606,788.00 -24.6%2.8%0.3 $16.67 8/31/202448,300 shares $888,720.00 -2.2%3.7%0.4 $18.40 8/15/202449,400 shares $803,738.00 -51.4%3.7%0.4 $16.27 7/31/2024101,700 shares $1.69 million +887.4%7.7%0.8 $16.60 Get the Latest News and Ratings for PIRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pieris Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/15/202410,300 shares $76,323.00 -42.5%0.8%0.1 $7.41 6/30/202417,900 shares $175,611.53 +32.6%1.5%1.1 $9.81 6/15/202413,500 shares $136,216.35 -20.6%1.1%1.1 $10.09 5/31/202417,000 shares $172,550.00 -31.5%1.4%1.2 $10.15 5/15/202424,800 shares $281,976.00 +93.8%2.0%1.7 $11.37 4/30/202412,800 shares $149,888.00 +4,166.7%1.1%0.9 $11.71 4/15/2024300 shares $4,080.00 -99.8%0.0%0 $13.60 3/31/2024134,100 shares $24,567.12 +222.4%N/A0.2 $0.18 3/15/202441,600 shares $7,030.40 -41.2%N/A0.1 $0.17 2/29/202470,700 shares $11,672.57 +6.8%N/A0.1 $0.17 2/15/202466,200 shares $10,505.94 -69.1%N/A0.1 $0.16 1/31/2024214,500 shares $39,661.05 +31.1%N/A0.4 $0.18 1/15/2024163,600 shares $29,268.04 +22.6%N/A0.3 $0.18 12/31/2023133,400 shares $24,278.80 -17.5%N/A0.2 $0.18 12/15/2023161,600 shares $26,680.16 +145.6%N/A0.3 $0.17 11/30/202365,800 shares $13,442.94 -3.1%N/A0.1 $0.20 11/15/202367,900 shares $15,725.64 -63.5%N/A0.1 $0.23 10/31/2023186,100 shares $44,273.19 -26.7%N/A0.1 $0.24 10/15/2023253,900 shares $72,006.04 -55.7%N/A0.1 $0.28 9/30/2023573,500 shares $170,903.00 -5.2%N/A0.2 $0.30 9/15/2023605,200 shares $188,822.40 -57.4%N/A0.2 $0.31 8/31/20231,420,000 shares $481,806.00 +35.2%N/A0.4 $0.34 8/15/20231,050,000 shares $252,420.00 -28.6%N/A0.3 $0.24 7/31/20231,470,000 shares $324,870.00 +293.8%N/A0.5 $0.22 7/15/2023373,300 shares $72,793.50 -84.6%N/A0.1 $0.20 6/30/20232,420,000 shares $400,510.00 +32.2%N/A1.6 $0.17 6/15/20231,830,000 shares $1.63 million -1.1%N/A1.4 $0.89 5/31/20231,850,000 shares $1.57 million +0.5%N/A2.6 $0.85 5/15/20231,840,000 shares $1.59 million -1.1%N/A3 $0.86 4/30/20231,860,000 shares $1.41 million +1.6%N/A5.4 $0.76 4/15/20231,830,000 shares $1.31 million -0.5%N/A6.8 $0.72 3/31/20231,840,000 shares $1.80 million +0.6%2.9%6.4 $0.98 3/15/20231,830,000 shares $2.67 million No Change2.9%5.9 $1.46 2/28/20231,830,000 shares $2.75 million -0.5%2.9%5.6 $1.50Sell NVDA Now? (Ad)Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%.Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA). 2/15/20231,840,000 shares $2.93 million -32.4%2.9%4.6 $1.59 1/31/20232,720,000 shares $4.35 million +70.0%N/A6.4 $1.60 1/15/20231,600,000 shares $2.40 million +0.6%N/A4.2 $1.50 12/30/20221,590,000 shares $1.65 million -4.2%N/A4.9 $1.04 12/15/20221,660,000 shares $1.63 million +0.6%N/A6.5 $0.98 11/30/20221,650,000 shares $1.61 million No ChangeN/A7.4 $0.98 11/15/20221,650,000 shares $1.61 million +1.9%N/A7.3 $0.98 10/31/20221,620,000 shares $1.80 million +14.1%N/A10 $1.11 10/15/20221,420,000 shares $1.42 million -4.7%2.3%8.4 $1.00 9/30/20221,490,000 shares $1.71 million +8.8%2.4%8 $1.15 9/15/20221,370,000 shares $1.89 million +5.4%2.2%6.8 $1.38 8/31/20221,300,000 shares $1.90 million -3.0%2.1%5.7 $1.46 8/15/20221,340,000 shares $2.29 million +9.8%2.1%5.1 $1.71 7/31/20221,220,000 shares $2.15 million +1.7%1.9%3.7 $1.76 7/15/20221,200,000 shares $2.26 million +3.5%1.9%3.3 $1.88 6/30/20221,160,000 shares $2.17 million +6.4%1.9%3.1 $1.87 6/15/20221,090,000 shares $1.80 million +18.0%1.7%2.7 $1.65 5/31/2022923,900 shares $1.64 million +45.3%1.5%2.3 $1.78 5/15/2022635,700 shares $1.09 million -11.8%1.0%1.5 $1.71 4/30/2022720,700 shares $2.02 million +12.6%1.2%1.7 $2.80 4/15/2022640,000 shares $2.01 million -42.9%1.0%1.4 $3.14 3/31/20221,120,000 shares $3.39 million +86.0%1.8%2.1 $3.03 3/15/2022602,200 shares $1.80 million -13.4%1.0%0.8 $2.99 2/28/2022695,100 shares $2.15 million +18.4%1.1%0.8 $3.09 2/15/2022587,100 shares $2.00 million -13.5%1.0%0.7 $3.40 1/31/2022678,500 shares $2.47 million -7.7%1.1%0.8 $3.64 1/15/2022734,900 shares $2.56 million -6.8%1.2%0.8 $3.49 12/31/2021788,700 shares $2.98 million +69.4%1.3%0.9 $3.78 12/15/2021465,500 shares $1.52 million -20.9%0.8%0.5 $3.26 11/30/2021588,800 shares $1.94 million -15.2%1.0%0.6 $3.30 11/15/2021694,000 shares $2.70 million -75.4%1.2%0.6 $3.89 10/29/20212,820,000 shares $12.92 million +75.2%4.7%2.1 $4.58 10/15/20211,610,000 shares $7.26 million +49.1%2.9%1.2 $4.51 9/30/20211,080,000 shares $5.58 million -1.8%1.9%0.7 $5.17 9/15/20211,100,000 shares $6.12 million +10.6%2.0%0.4 $5.56 8/31/2021994,200 shares $5.36 million -9.6%1.8%0.3 $5.39 8/13/20211,100,000 shares $4.22 million -47.6%2.0%0.1 $3.84 7/30/20212,100,000 shares $7.31 million -30.0%3.8%0.2 $3.48 7/15/20213,000,000 shares $10.56 million -11.2%5.8%0.3 $3.52 6/30/20213,380,000 shares $12.95 million -14.4%6.5%0.3 $3.83 6/15/20213,950,000 shares $13.79 million -44.0%7.6%0.4 $3.49 5/28/20217,050,000 shares $24.25 million +173.3%13.5%0.8 $3.44 5/14/20212,580,000 shares $4.82 million -8.5%N/A0.4 $1.87 4/30/20212,820,000 shares $6.23 million +10.6%6.0%4.5 $2.21 4/15/20212,550,000 shares $5.33 million +0.4%5.4%4.4 $2.09 3/31/20212,540,000 shares $6.35 million +8.1%N/A4.9 $2.50 3/15/20212,350,000 shares $6.20 million -6.4%N/A6 $2.64 2/26/20212,510,000 shares $7.03 million +8.2%N/A6.1 $2.80 2/12/20212,320,000 shares $6.80 million +13.2%N/A5.9 $2.93 1/29/20212,050,000 shares $5.23 million -1.0%N/A6 $2.55Sell NVDA Now? (Ad)Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%.Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA). 1/15/20212,070,000 shares $5.78 million -3.7%N/A5.8 $2.79 12/31/20202,150,000 shares $5.70 million +9.7%N/A6.3 $2.65 12/15/20201,960,000 shares $5.23 million +5.4%N/A5.3 $2.67 11/30/20201,860,000 shares $5.49 million -7.9%N/A4.8 $2.95 11/15/20202,020,000 shares $5.51 million -8.2%N/A5.4 $2.73 10/30/20202,200,000 shares $5.37 million +26.4%N/A5.4 $2.44 10/15/20201,740,000 shares $4.15 million -3.9%N/A3.8 $2.39 9/30/20201,810,000 shares $3.75 million -1.1%N/A3.6 $2.07 9/15/20201,830,000 shares $5.38 million -2.7%N/A3.6 $2.94 8/31/20201,880,000 shares $5.38 million -1.6%N/A4 $2.86 8/14/20201,910,000 shares $5.83 million -1.0%N/A3.8 $3.05 7/31/20201,930,000 shares $4.96 million -16.8%N/A3.9 $2.57 7/15/20202,320,000 shares $6.80 million +2.7%N/A5.7 $2.93 6/30/20202,260,000 shares $7.21 million +16.5%N/A6.3 $3.19 6/15/20201,940,000 shares $5.90 million -4.9%N/A5.1 $3.04 5/29/20202,040,000 shares $7.34 million +4.1%N/A4.4 $3.60 5/15/20201,960,000 shares $5.47 million +9.5%N/A4.3 $2.79 4/30/20201,790,000 shares $4.74 million +1.1%N/A4 $2.65 4/15/20201,770,000 shares $4.57 million +0.6%N/A3.3 $2.58 3/31/20201,760,000 shares $5.00 million +25.2%N/A3.2 $2.84 3/13/20201,405,300 shares $3.56 million -5.7%N/A2.9 $2.53 2/28/20201,490,000 shares $3.11 million +8.8%N/A3 $2.09 2/14/20201,370,000 shares $3.52 million -16.0%2.9%2.7 $2.57 1/31/20201,630,000 shares $5.56 million +38.1%3.4%2.8 $3.41 1/15/20201,180,000 shares $4.72 million -32.6%2.4%2.1 $4.00 12/31/20191,750,000 shares $5.65 million -6.9%3.6%3.3 $3.23 PIRS Short Interest - Frequently Asked Questions What is Pieris Pharmaceuticals' current short interest? Short interest is the volume of Pieris Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 15th, investors have sold 26,800 shares of PIRS short. 2.03% of Pieris Pharmaceuticals' shares are currently sold short. Learn More on Pieris Pharmaceuticals' current short interest. What is a good short interest percentage for Pieris Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.03% of Pieris Pharmaceuticals' floating shares are currently sold short. Is Pieris Pharmaceuticals' short interest increasing or decreasing? Pieris Pharmaceuticals saw a drop in short interest during the month of October. As of October 15th, there was short interest totaling 26,800 shares, a drop of 2.2% from the previous total of 27,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Pieris Pharmaceuticals' float size? Pieris Pharmaceuticals currently has issued a total of 1,320,000 shares. Some of Pieris Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Pieris Pharmaceuticals currently has a public float of 1,320,000 shares. How does Pieris Pharmaceuticals' short interest compare to its competitors? 2.03% of Pieris Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Pieris Pharmaceuticals: FibroGen, Inc. (4.01%), BeyondSpring Inc. (8.42%), Genelux Co. (3.75%), PMV Pharmaceuticals, Inc. (2.24%), Onconetix, Inc. (0.31%), CervoMed Inc. (23.74%), Ovid Therapeutics Inc. (1.04%), DBV Technologies S.A. (0.35%), Clearside Biomedical, Inc. (2.61%), CASI Pharmaceuticals, Inc. (2.57%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Pieris Pharmaceuticals stock? Short selling PIRS is an investing strategy that aims to generate trading profit from Pieris Pharmaceuticals as its price is falling. PIRS shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Pieris Pharmaceuticals? A short squeeze for Pieris Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PIRS, which in turn drives the price of the stock up even further. How often is Pieris Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PIRS, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies FGEN Short Squeeze BYSI Short Squeeze GNLX Short Squeeze PMVP Short Squeeze ONCO Short Squeeze CRVO Short Squeeze OVID Short Squeeze DBVT Short Squeeze CLSD Short Squeeze CASI Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PIRS) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pieris Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pieris Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
